Pharmabiz7d
Boehringer Ingelheim & WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, pledged USD 5 million to advance access to quality healthcare services for ...
US FDA approves Elanco's treatment for parasitic infections in dogs
The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect dogs against six parasitic ...
Pharmabiz12d
Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment
Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment: Ingelheim, Germany Friday, October 11, 2024, 12:00 Hrs [IST] Boehring ...
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis ...
pharmaphorum22d
Boosted by new drugs, Boehringer shrugs off patent expiry
As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking ... along with the integration of a new animal health business bought from Sanofi ...
Financial Post26d
Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on developing ...
Farmers Weekly28d
First new bluetongue vaccines available for use
Boehringer Ingelheim’s Bultavo 3 is among the first vaccines delivered, along with Virbac’s Syvazul BTV3, while Ceva Animal Health’s Bluevac-3 will be available in the UK from mid-October.
Zawya7d
More than 300 regional experts gather in Cairo for Boehringer Ingelheim’s Forums
Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts ...
EuropaWire8d
Boehringer Ingelheim and WHO Foundation Collaborate to Boost Global Healthcare Access and Suicide Prevention Efforts
Boehringer Ingelheim and the WHO Foundation have partnered to promote equitable healthcare access and suicide prevention, with a focus on vulnera ...
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...